X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 08/Nov 14:20

AlTi Global, Inc. (ALTI) Tops Q3 Earnings Estimates

AlTi Global, Inc. (ALTI) delivered earnings and revenue surprises of 3,700% and 4.06%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Articles similaires

Sorry! Image not available at this time

Urogen Pharma (URGN) Reports Q3 Loss, Tops Revenue Estimates

zacks.com - 06/Nov 14:15

Urogen Pharma (URGN) delivered earnings and revenue surprises of 34.52% and 4.06%, respectively, for the quarter ended September 2024. Do the numbers...

Sorry! Image not available at this time

GDEV Inc. (GDEV) Tops Q3 Earnings and Revenue Estimates

zacks.com - 14/Nov 16:05

GDEV Inc. (GDEV) delivered earnings and revenue surprises of 107.89% and 6.56%, respectively, for the quarter ended September 2024. Do the numbers...

Sorry! Image not available at this time

GDEV Inc. (GDEV) Tops Q3 Earnings and Revenue Estimates

zacks.com - 14/Nov 16:05

GDEV Inc. (GDEV) delivered earnings and revenue surprises of 107.89% and 6.56%, respectively, for the quarter ended September 2024. Do the numbers...

Sorry! Image not available at this time

Aadi Bioscience, Inc. (AADI) Reports Q3 Loss, Tops Revenue Estimates

zacks.com - 06/Nov 14:10

Aadi Bioscience (AADI) delivered earnings and revenue surprises of 0% and 10.11%, respectively, for the quarter ended September 2024. Do the numbers...

Sorry! Image not available at this time

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates

zacks.com - 05/Nov 22:10

Rhythm Pharmaceuticals (RYTM) delivered earnings and revenue surprises of 8.75% and 2.36%, respectively, for the quarter ended September 2024. Do the...

Sorry! Image not available at this time

AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Tops Revenue Estimates

zacks.com - 05/Nov 22:30

AnaptysBio (ANAB) delivered earnings and revenue surprises of 33.72% and 279.19%, respectively, for the quarter ended September 2024. Do the numbers...

Sorry! Image not available at this time

Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates

zacks.com - 06/Nov 13:15

Tango Therapeutics (TNGX) delivered earnings and revenue surprises of 20.59% and 44.35%, respectively, for the quarter ended September 2024. Do the...

Sorry! Image not available at this time

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates

zacks.com - 12/Nov 22:35

Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of -11.11% and 12.30%, respectively, for the quarter ended September 2024. Do the...

Sorry! Image not available at this time

Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates

zacks.com - 12/Nov 22:35

Hyperfine (HYPR) delivered earnings and revenue surprises of 0% and 7.31%, respectively, for the quarter ended September 2024. Do the numbers hold...

Sorry! Image not available at this time

BioLife Solutions, Inc. (BLFS) Reports Q3 Loss, Tops Revenue Estimates

zacks.com - 12/Nov 22:45

BioLife Solutions (BLFS) delivered earnings and revenue surprises of 77.78% and 21.98%, respectively, for the quarter ended September 2024. Do the...